Prognostic factors and antibiotics in Vibrio vulnificus septicemia

Jien Wei Liu, Ing Kit Lee, Hung Jen Tang, Wen Chien Ko, Hsin Chun Lee, Yung-Ching Liu, Po Ren Hsueh, Yin Ching Chuang

研究成果: 雜誌貢獻文章

55 引文 斯高帕斯(Scopus)

摘要

Background: Immunocompromised patients with Vibrio vulnificus septicemia are at high risk for fatality. When a hemorrhagic bullous necrotic cutaneous lesion (HBNCL) and decreased blood pressure develop, approximately 50% of V vulnificus septicemic patients die within 48 hours. This study aimed to evaluate the risk factor(s) for fatality among patients with V vulnificus septicemia, emphasizing the role of prescribed antimicrobial agents in general and the therapeutic efficacy of the combination of a third-generation cephalosporin and tetracycline or its analogue in particular. Methods: Patients with the diagnosis of V vulnificus infection admitted to 5 large medical centers in Taiwan between 1995 and 2003 were included in this retrospective study. Patients were divided into 2 groups: those with HBNCLs and those without HBNCLs. Patients were further divided into subgoups without fatalities (fatal subgroup) and those without fatalities (nonfatal subgroup). Results: A total of 93 patients participated in the study. In group 1, the fatal subgroup had higher Acute Physiology and Chronic Health Evaluation II (APACHE II) scores (P=.006) and a higher proportion of shock at arrival at the medical center (P=.015) than the nonfatal subgroup. In group 2, the effect of a first- or secondgeneration cephalosporin plus an aminoglycoside was negative (P = .01) and that of combined third-generation cephalosporin and tetracycline or its analogue was positive (P
原文英語
頁(從 - 到)2117-2123
頁數7
期刊Archives of Internal Medicine
166
發行號19
DOIs
出版狀態已發佈 - 十月 23 2006
對外發佈Yes

    指紋

ASJC Scopus subject areas

  • Internal Medicine

引用此

Liu, J. W., Lee, I. K., Tang, H. J., Ko, W. C., Lee, H. C., Liu, Y-C., Hsueh, P. R., & Chuang, Y. C. (2006). Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Archives of Internal Medicine, 166(19), 2117-2123. https://doi.org/10.1001/archinte.166.19.2117